Lead Product(s) : JQ-1,Molibresib
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
UNH Researchers Discover New Inhibitor Drug Combination for Rare Form of Cancer
Details : Researchers at the University found that adding venetoclax or panabinostat to the inhibitors was more effective than adding ibrutinib—with panobinostat offering the greatest combination therapy.
Product Name : JQ-1
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 14, 2021
Lead Product(s) : JQ-1,Molibresib
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable